Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults

A live attenuated zoster vaccine (ZOSTAVAX™, Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the vaccine has not been assessed in Korean population. This is multi-center, open-label, single-arm study performed with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Korean Med Sci
Egile Nagusiak: Choi, Won Suk, Choi, Jung-Hyun, Choi, Jun Yong, Eom, Joong Sik, Kim, Sang Il, Pai, Hyunjoo, Peck, Kyong Ran, Sohn, Jang Wook, Cheong, Hee Jin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Academy of Medical Sciences 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://ncbi.nlm.nih.gov/pubmed/26770032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.1.13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak